|
AP1019A
(en)
|
1996-10-18 |
2001-10-16 |
Vertex Pharma |
Inhibitors of serinre proteases, particularly hepatitis C virus NS3 protease.
|
|
SV2003000617A
(es)
|
2000-08-31 |
2003-01-13 |
Lilly Co Eli |
Inhibidores de la proteasa peptidomimetica ref. x-14912m
|
|
ITRE20010042A1
(it)
*
|
2001-04-24 |
2002-10-24 |
Corghi Spa |
Dispositivo sollevatore per macchine smontagomme
|
|
JP2003007697A
(ja)
*
|
2001-06-21 |
2003-01-10 |
Hitachi Kokusai Electric Inc |
半導体装置の製造方法、基板処理方法および基板処理装置
|
|
UY28500A1
(es)
|
2003-09-05 |
2005-04-29 |
Vertex Pharma |
Inhibidores de proteasas de serina, en particular proteasa ns3-ns4a del vhc.
|
|
US7491794B2
(en)
|
2003-10-14 |
2009-02-17 |
Intermune, Inc. |
Macrocyclic compounds as inhibitors of viral replication
|
|
WO2005087721A2
(en)
*
|
2004-02-27 |
2005-09-22 |
Schering Corporation |
Compounds as inhibitors of hepatitis c virus ns3 serine protease
|
|
AU2005219824B2
(en)
*
|
2004-02-27 |
2007-11-29 |
Merck Sharp & Dohme Corp. |
Novel ketoamides with cyclic p4's as inhibitors of ns3 serine protease of hepatitis c virus
|
|
NZ563365A
(en)
*
|
2005-06-02 |
2011-02-25 |
Schering Corp |
Combination of HCV protease inhibitors with a surfactant
|
|
US20060276404A1
(en)
*
|
2005-06-02 |
2006-12-07 |
Anima Ghosal |
Medicaments and methods combining a HCV protease inhibitor and an AKR competitor
|
|
NZ563361A
(en)
|
2005-06-02 |
2011-02-25 |
Schering Corp |
HCV protease inhibitors in combination with food
|
|
US20070237818A1
(en)
*
|
2005-06-02 |
2007-10-11 |
Malcolm Bruce A |
Controlled-release formulation of HCV protease inhibitor and methods using the same
|
|
AU2006276246B2
(en)
*
|
2005-07-25 |
2012-09-27 |
Intermune, Inc. |
Novel macrocyclic inhibitors of hepatitis C virus replication
|
|
US8399615B2
(en)
|
2005-08-19 |
2013-03-19 |
Vertex Pharmaceuticals Incorporated |
Processes and intermediates
|
|
WO2007022459A2
(en)
|
2005-08-19 |
2007-02-22 |
Vertex Pharmaceuticals Incorporated |
Processes and intermediates
|
|
US7964624B1
(en)
|
2005-08-26 |
2011-06-21 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases
|
|
AR055395A1
(es)
|
2005-08-26 |
2007-08-22 |
Vertex Pharma |
Compuestos inhibidores de la actividad de la serina proteasa ns3-ns4a del virus de la hepatitis c
|
|
ES2356776T3
(es)
*
|
2005-10-11 |
2011-04-13 |
Intermune, Inc. |
Compuestos y métodos para inhibir la replicación del virus de la hepatitis.
|
|
EP2392589A3
(en)
|
2005-11-11 |
2012-06-20 |
Vertex Pharmaceuticals Incorporated |
Hepatitis C virus variants
|
|
US7705138B2
(en)
|
2005-11-11 |
2010-04-27 |
Vertex Pharmaceuticals Incorporated |
Hepatitis C virus variants
|
|
US8183413B2
(en)
|
2006-01-20 |
2012-05-22 |
Kaneka Corporation |
Process for production of β-amino-α-hydroxy carboxamide derivative
|
|
US7816348B2
(en)
|
2006-02-03 |
2010-10-19 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
|
AU2007217355B2
(en)
|
2006-02-27 |
2012-06-21 |
Vertex Pharmaceuticals Incorporated |
Co-crystals comprising VX-950 and pharmaceutical compositions comprising the same
|
|
JP2009132621A
(ja)
*
|
2006-03-13 |
2009-06-18 |
Ajinomoto Co Inc |
シクロプロピルアミド化合物の製造方法
|
|
WO2007109080A2
(en)
|
2006-03-16 |
2007-09-27 |
Vertex Pharmaceuticals Incorporated |
Deuterated hepatitis c protease inhibitors
|
|
RU2008144294A
(ru)
*
|
2006-04-11 |
2010-05-20 |
Новартис АГ (CH) |
Ингибиторы вируса гепатита с (hcv)
|
|
AU2007249668B2
(en)
*
|
2006-04-11 |
2011-04-07 |
Novartis Ag |
HCV/HIV inhibitors and their uses
|
|
US20080045530A1
(en)
*
|
2006-04-11 |
2008-02-21 |
Trixi Brandl |
Organic Compounds and Their Uses
|
|
WO2007138928A1
(ja)
|
2006-05-26 |
2007-12-06 |
Kaneka Corporation |
光学活性３－アミノ－２－ヒドロキシプロピオン酸シクロプロピルアミド誘導体およびその塩の製造方法
|
|
DE102006059317A1
(de)
*
|
2006-07-04 |
2008-01-10 |
Evonik Degussa Gmbh |
Verfahren zur Herstellung von β-Amino-α-hydroxy-carbonsäureamiden
|
|
RU2008152171A
(ru)
*
|
2006-07-05 |
2010-08-10 |
Интермьюн, Инк. (Us) |
Новые ингибиторы вирусной репликации гепатита с
|
|
RU2009109355A
(ru)
|
2006-08-17 |
2010-09-27 |
БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE) |
Ингибиторы вырусной полимеразы
|
|
US20100081672A1
(en)
*
|
2006-12-07 |
2010-04-01 |
Schering Corporation |
Ph sensitive matrix formulation
|
|
WO2008106058A2
(en)
|
2007-02-27 |
2008-09-04 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases
|
|
HRP20120330T1
(hr)
|
2007-02-27 |
2012-05-31 |
Vertex Pharmaceuticals Incorporated |
Sukristali i farmaceutski pripravci koji ih sadrže
|
|
SG174809A1
(en)
*
|
2007-05-03 |
2011-10-28 |
Intermune Inc |
Macrocyclic compounds useful as inhibitors of hepatitis c virus
|
|
JP2010526834A
(ja)
*
|
2007-05-10 |
2010-08-05 |
インターミューン・インコーポレーテッド |
Ｃ型肝炎ウイルス複製の新規ペプチド阻害剤
|
|
US8242140B2
(en)
|
2007-08-03 |
2012-08-14 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
|
NZ583699A
(en)
|
2007-08-30 |
2012-04-27 |
Vertex Pharma |
Co-crystals of vx-950 (telaprevir) other components and pharmaceutical compositions comprising the same
|
|
CN101868452B
(zh)
*
|
2007-10-10 |
2014-08-06 |
诺华股份有限公司 |
螺环吡咯烷类与其对抗hcv和hiv感染的应用
|
|
US8106059B2
(en)
*
|
2007-10-24 |
2012-01-31 |
Virobay, Inc. |
Substituted pyrazines that inhibit protease cathepsin S and HCV replication
|
|
EP2234977A4
(en)
|
2007-12-19 |
2011-04-13 |
Boehringer Ingelheim Int |
VIRAL POLYMERASE INHIBITORS
|
|
WO2009142842A2
(en)
|
2008-04-15 |
2009-11-26 |
Intermune, Inc. |
Novel macrocyclic inhibitors of hepatitis c virus replication
|
|
CN102816106A
(zh)
*
|
2008-06-24 |
2012-12-12 |
默沙东公司 |
用于制备基本上立体异构纯的稠合二环脯氨酸化合物的生物催化方法
|
|
CN102271699A
(zh)
|
2009-01-07 |
2011-12-07 |
西尼克斯公司 |
用于治疗hcv和hiv感染的环孢菌素衍生物
|
|
AR075584A1
(es)
|
2009-02-27 |
2011-04-20 |
Intermune Inc |
COMPOSICIONES TERAPEUTICAS QUE COMPRENDEN beta-D-2'-DESOXI-2'-FLUORO-2'-C-METILCITIDINA Y UN DERIVADO DE ACIDO ISOINDOL CARBOXILICO Y SUS USOS. COMPUESTO.
|
|
US20110182850A1
(en)
*
|
2009-04-10 |
2011-07-28 |
Trixi Brandl |
Organic compounds and their uses
|
|
US8512690B2
(en)
*
|
2009-04-10 |
2013-08-20 |
Novartis Ag |
Derivatised proline containing peptide compounds as protease inhibitors
|
|
CA2763140A1
(en)
|
2009-05-29 |
2010-12-02 |
Schering Corporation |
Antiviral compounds composed of three linked aryl moieties to treat diseases such as hepatitis c
|
|
JP2013512246A
(ja)
|
2009-11-25 |
2013-04-11 |
メルク・シャープ・アンド・ドーム・コーポレーション |
ウイルス疾患治療に有用な縮合型三環式化合物およびその誘導体
|
|
US20130156731A1
(en)
|
2009-12-22 |
2013-06-20 |
Kevin X. Chen |
Fused tricyclic compounds and methods of use thereof for the treatment of viral diseas
|
|
EA201290882A1
(ru)
|
2010-03-09 |
2013-04-30 |
Мерк Шарп Энд Домэ Корп. |
Конденсированные трициклические силильные соединения и способы их применения для лечения вирусных заболеваний
|
|
WO2012018534A2
(en)
|
2010-07-26 |
2012-02-09 |
Schering Corporation |
Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases
|
|
JP2013540122A
(ja)
|
2010-09-29 |
2013-10-31 |
メルク・シャープ・エンド・ドーム・コーポレイション |
縮合四環式化合物誘導体およびウィルス疾患治療のためのそれの使用方法
|
|
WO2012142075A1
(en)
|
2011-04-13 |
2012-10-18 |
Merck Sharp & Dohme Corp. |
2'-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
|
BR112013026345A2
(pt)
|
2011-04-13 |
2019-04-24 |
Merck Sharp & Dohe Corp. |
composto, composição farmacêutica, uso de um composto, e, método para tratar um paciente infectado com hcv
|
|
WO2012158515A1
(en)
*
|
2011-05-13 |
2012-11-22 |
Vertex Phamaceuticals Incorporated |
Process for the preparation of protease inhibitors
|
|
WO2012158513A1
(en)
*
|
2011-05-13 |
2012-11-22 |
Vertex Pharmaceuticals Incorporated |
Processes and intermediates
|
|
WO2013033901A1
(en)
|
2011-09-08 |
2013-03-14 |
Merck Sharp & Dohme Corp. |
Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseases
|
|
WO2013033900A1
(en)
|
2011-09-08 |
2013-03-14 |
Merck Sharp & Dohme Corp. |
Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases
|
|
WO2013033899A1
(en)
|
2011-09-08 |
2013-03-14 |
Merck Sharp & Dohme Corp. |
Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases
|
|
US20140378416A1
(en)
|
2011-09-14 |
2014-12-25 |
Michael P. Dwyer |
Silyl-containing heterocyclic compounds and methods of use thereof for the treatment of viral diseases
|
|
AR091192A1
(es)
|
2012-05-30 |
2015-01-21 |
Chemo Iberica Sa |
Procedimiento multicomponente para la preparacion de compuestos biciclicos
|
|
CN103508918B
(zh)
*
|
2012-06-18 |
2015-09-09 |
上海医药工业研究院 |
带有环丁基的α-羟基β-氨基酯类化合物及其制备方法
|
|
ITMI20122205A1
(it)
*
|
2012-12-20 |
2014-06-21 |
Dipharma Francis Srl |
Sintesi di un intermedio di un inibitore delle proteasi virali
|
|
CN103387510B
(zh)
*
|
2013-08-08 |
2015-09-09 |
苏州永健生物医药有限公司 |
一种β-氨基-alpha-羟基环丁基丁酰胺盐酸盐的合成方法
|
|
WO2015065817A1
(en)
|
2013-10-30 |
2015-05-07 |
Merck Sharp & Dohme Corp. |
Pseudopolymorphs of an hcv ns5a inhibitor and uses thereof
|
|
CN103664739B
(zh)
*
|
2013-12-10 |
2016-04-27 |
湖南科源生物制品有限公司 |
一种特拉匹韦中间体的制备方法
|
|
CN104926712B
(zh)
*
|
2014-03-20 |
2018-03-23 |
上海医药工业研究院 |
合成特拉匹韦的中间体及其制备方法
|